Natco Pharma announced on Thursday that it received a Form 483 from the United States Food and Drug Administration (USFDA) with seven observations following an inspection of its pharmaceutical division in Hyderabad...
In an interaction with India Pharma Outlook, Dr. Ganesh Babu, Head of Clinical and Regulatory Affairs at Carl Zeiss India, discusses how optical imaging technologies like fluorescence imaging and OCT are revolutionizing cancer detection. He highlight
India's domestic pharmaceutical industry will be subject to heightened scrutiny in light of ongoing quality control issues among domestic manufacturers, a reported by BMI stated...
Eli Lilly's experimental obesity drug, eloralintide, has shown promising early-stage data supporting weight loss of an average of 11.5 percent after only 12 weeks, said an investor note from Cantor Fitzgerald...
Leading diagnostic chains in India are scaling up operations amid a sharp rise in Covid-19 cases, driven by new variants such as JN.1, NB.1.8.1, and LF.7. According to diagnostic labs, RT-PCR tests have risen by 70 percent as people become more aware
The Union Health Ministry has issued a draft notification proposing a ban on the manufacture, import, sale, and distribution of 34 antimicrobials
The National Accreditation Board for Testing and Calibration Laboratories (NABL) is encouraging its accredited Conformity Assessment Bodies
Bayer has initiated a Phase I clinical trial for BAY 3670549, a first-in-class, highly selective G-protein-coupled inwardly rectifying potassium channel 4 (GIRK4) inhibitor, targeting atrial fibrillation (AFib)...
Bharat Biotech International Ltd announced that it successfully completed Phase III clinical trials for its oral cholera vaccine, Hillchol. The double-blind, randomized study evaluated Hillchol for safety, immunogenicity, and consistency, and...
Tata 1mg has partnered with Unicommerce, a leading e-commerce enablement SaaS platform in India, to boost its order processing and logistics capabilities. Through this collaboration, Tata 1mg aims to automate and streamline its backend operations...